Efficacy and safety of individualized growth hormone treatment in adult Japanese patients with growth hormone deficiency

Growth Hormone and IGF Research

Volumn 18, Issue 5, 2008, Pages 394-403

  Chihara, Kazuo ^a   Kato, Yuzuru ^b   Shimatsu, Akira ^c   Tanaka, Toshiaki ^d   Kohno, Hitoshi ^e  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SHIMANE UNIVERSITY   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^d NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^e FUKUOKA CHILDREN S HOSPITAL   (Japan)

Author keywords

Growth hormone deficiency; Hypopituitarism; Recombinant human growth hormone

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HUMAN GROWTH HORMONE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TRIACYLGLYCEROL;

ADULT; AGED; ARTHRALGIA; ARTICLE; BODY COMPOSITION; BODY FAT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EDEMA; FEMALE; FLUID RETENTION; GROWTH HORMONE DEFICIENCY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; JAPAN; JAPANESE; LEAN BODY WEIGHT; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PARALLEL DESIGN; PERIPHERAL EDEMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TRUNK; UPPER RESPIRATORY TRACT INFECTION;

ADULT; BODY COMPOSITION; DEFICIENCY DISEASES; DOUBLE-BLIND METHOD; FEMALE; GROWTH DISORDERS; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; JAPAN; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME;

EID: 46749111484     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2008.02.002     Document Type: Article

References (32)

1. Carroll P., and Christ E. The growth hormone research society scientific committee, growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. J. Clin. Endocrinol. Metab. 83 (1998) 382-395
2. Shalet S., Toogood A., Rahim A., and Brennan B. The diagnosis of growth hormone deficiency in children and adults. Endocr. Rev. 19 (1998) 203-223
3. Beshyah S.A., Henderson A., Niththyananthan R., Skinner E., Anyaoku V., Richmond W., et al. The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance. J. Clin. Endocrinol. Metab. 80 2 (1995) 356-363
4. Rosén T., and Bengtsson B.A. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336 8710 (1990) 285-288
5. Bulow B., Hagmar L., Mikoczy Z., Nordstrom C.H., and Erfurth E.M. Increased cerebrovascular mortality in patients with hypopituitarism. Clin. Endocrinol. 46 (1997) 75-81
6. Bates A.S., Van't Hoff W., Jones P.J., and Clayton R.N. The effect of hypopituitarism on life expectancy. J. Clin. Endocrinol. Metab. 81 (1996) 1169-1172
7. Tomlinson J.W., Holden N., Hills R.K., Wheatley K., Clayton R.N., Bates A.S., et al. Association between premature mortality and hypopituitarism. Lancet 357 9254 (2001) 425-431
8. Irie M., Itoh Y., Miyashita Y., Tsushima T., and Shirai K. Complications in adults with growth hormone deficiency - a survey study in Japan. Endocr. J. 51 5 (2004) 479-485
9. Murakami Y., and Kato Y. Hypercholesteremia and obesity in adult patients with hypopituitarism: a report of a nationwide survey in Japan. Endocr. J. 50 (2003) 759-765
10. Attanasio A.F., Lamberts S.W., Matranga A.M., Birkett M.A., Bates P.C., Valk N.K., et al. Adult growth hormone (GH) deficient patients demonstrate heterogeneity between childhood and adult onset before and during human GH treatment. J. Clin. Endocrinol. Metab. 82 (1997) 82-88
11. Gibney J., Wallace J.D., Spinks T., Schnorr L., Ranicar A., Cuneo R.C., et al. The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients. J. Clin. Endocrinol. Metab. 84 (1999) 2596-2602
12. Growth Hormone Research Society (GHRS). Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the growth hormone research society workshop on adult growth hormone deficiency. J. Clin. Endocrinol. Metab. 83 (1998) 379-381
13. Bengtsson B.A., Abs R., Bennmarker H., Monson J.P., Feldt-Rasmussen U., Hernberg-Stahl E., et al. The effects of treatment and the individual responsiveness to growth hormone replacement therapy in 665 GH-deficient adults. J. Clin. Endocrinol. Metab. 84 (1999) 3929-3935
14. Salomon F., Cuneo R.C., Hesp R., and Sönksen P.H. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N. Engl. J. Med. 321 (1989) 1797-1803
15. Jorgensen J.O., Pedersen S.A., Thuesen L., Jorgensen J., Ingemann-Hansen T., Skakkebaek N.E., and Christiansen J.S. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1 8649 (1989) 1221-1225
16. Chihara K., Koledova E., Shimatsu A., Kato Y., Kohno H., Tanaka T., et al. Adult GH deficiency in Japanese patients: effects of GH treatment in a randomised, placebo-controlled trial. Eur. J. Endocrinol. 151 (2004) 343-350
17. Ito H., Nakasuga K., Ohshima A., Maruyama T., Kaji Y., Harada M., et al. Detection of cardiovascular risk factors by indices of obesity obtained from anthropometry and dual-energy X-ray absorptiometry in Japanese individuals. Int. J. Obes. 27 (2003) 232-237
18. Johannsson G., Rosen T., and Bengtsson B.-A. Individualised dose titration of growth hormone during GH replacement in hypopituitary adults. Clin. Endocrinol. 47 (1997) 571-581
19. Drake W.M., Coyte D., Camacho-Hübner C., Jivanji N.M., Kaltsas G., Wood D.F., et al. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults. J. Clin. Endocrinol. Metab. 83 (1998) 3913-3919
20. Treasure T., and MacRae K.D. Minimisation: the platinum standard for trials? Randomisation doesn't guarantee similarity of groups; minimisation does. BMJ 317 (1998) 362-363
21. Chihara K., Koledova E., Shimatsu A., Kato Y., Kohno H., Tanaka T., et al. An individualised GH dose regimen for long-term GH treatment in Japanese patients with adult GH deficiency. Eur. J. Endocrinol. 153 (2005) 57-65
22. Kehely A., Bates P.C., Frewer P., Birkett M., Blum W.F., Mamessier P., et al. Short-term safety and efficacy of human GH replacement therapy in 595 adults with GH deficiency: a comparison of two dosage algorithms. J. Clin. Endocrinol. Metab. 87 (2002) 1974-1979
23. Kuromaru R., Kohno H., Ueyama N., Hassan H.M., Honda S., and Hara T. Long-term prospective study of body composition and lipid profiles during and after growth hormone (GH) treatment in children with GH deficiency: gender-specific metabolic effects. J. Clin. Endocrinol. Metab. 83 (1998) 3890-3896
24. Kaji H., Sakurai T., Iguchi G., Murata M., Kishimoto M., Yoshioka S., et al. Adult growth hormone deficiency in Japan: results of investigation by questionnaire. Endocr. J. 49 (2002) 597-604
25. The Examination Committee of Criteria for Obesity Disease in Japan. Japan society for the study of obesity. New criteria for obesity disease in Japan. Circulation 66 (2002) 987-992
26. Simpson H., Savine R., Sönksen P., Bengtsson B.A., Carlsson L., Christiansen J.S., et al. GRS council, growth hormone replacement therapy for adults: into the new millennium. Growth Horm. IGF Res. 12 (2002) 1-33
27. Abs R., Feldt-Rasmussen U., Mattsson A.F., Monson J.P., Bengtsson B.A., Góth M.I., et al. Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis. Eur. J. Endocrinol. 155 (2006) 79-90
28. Suka M., Sugimori H., and Yoshida K. Application of the updated Framingham risk score to Japanese men. Hypertens. Res. 24 (2001) 685-689
29. Kuromaru R., Kohno H., and Hara T. Changes in adiposity and excess body weight correlate with growth responses but not with decreases in low-density lipoprotein cholesterol levels during GH treatment in GH-deficient children. Clin. Endocrinol. 56 (2002) 799-803
30. Growth Hormone Research Society. Critical evaluation of the safety of recombinant human growth hormone administration: statement from the Growth Hormone Research Society. J. Clin. Endocrinol. Metab. 86 (2001) 1868-1870
31. Hoffman A.R., Strasburger C.J., Zagar A., Blum W.F., Kehely A., Hartman M.L., and T002 Study Group. Efficacy and tolerability of an individualized dosing regimen for adult growth hormone replacement therapy in comparison with fixed body weight-based dosing. J. Clin. Endocrinol. Metab. 89 (2004) 3224-3233
32. Chipman J.J., Attanasio A.F., Birkett M.A., Bates P.C., Webb S., and Lamberts S.W. The safety profile of GH replacement therapy in adults. Clin. Endocrinol. 46 (1997) 473-481